An Extension Study to Evaluate the Long Term Safety, Tolerability and Efficacy of Aliskiren Compared to Enalapril in Pediatric Hypertensive Patients 6-17 Years of Age
- Status
- COMPLETED
- Phase
- PHASE3
Related studies linked through entity extraction aliases.